1. 这是一项前瞻性随机、双盲、安慰剂对照研究,纳入70名18-60岁有幽门螺杆菌感染的成年人,随机分为2组: 罗伊氏乳杆菌组(n=35):接受14天标准三联疗法(奥美拉唑+阿莫西林+克拉霉素,每日2次)治疗,并从接受治疗开始补充益生菌咀嚼片(含罗伊氏乳杆菌DSM 17938和罗伊氏乳杆菌ATCC PTA 6475,每日1次,每次1片,2亿...
1. 单独使用Gastrus(含罗伊氏乳杆菌DSM 17938和罗伊氏乳杆菌ATCC PTA 6475)可以抑制幽门螺杆菌的生长,改善胃肠道症状; 2. 根除治疗联合Gastrus使用时,可以显著减少抗生素相关副作用的发生,降低血清G17水平,并(不显著地)提高了幽门螺杆菌的根除率。 文献来源 Lactobacillus reuteri strain combination in Helicobacterpy...
英文名称:Lactobacillus reuteri 尺寸:冻干粉 特性:0代母种 灭菌情况:灭菌,单一菌种 储存条件:4-10℃ 大包装询价 产品介绍相关文档质检证书(COA)相关文献订购须知 菌种名:罗伊氏乳杆菌 拉丁名:Lactobacillus reuteri 菌种编号:SHMCC(SHBCC) D24591 其他编号:DSM26866 ...
ATCC PTA 6475 (LR) is a well-known probiotic that has been shown to be beneficial to the gastrointestinal (GI) system. In addition, LR has been shown to secrete beneficial immunomodulatory factors. In previous studies, we demonstrated that LR can modulate inflammatory genes in the GI tract ...
最近研究发现,多种人源罗伊氏乳杆菌,包括DSM17938、ATCCPTA4659、ATCCPTA5289和ATCCPTA6475等均可通过单核吞噬细胞系统来刺激免疫调节反应,进而不同程度地减轻人类肠道炎症。用因腹腔接种LP-BM5白血病毒而患免疫缺陷症的C57BL小鼠作为实验对象,来检测罗伊氏乳杆菌对小球隐孢子虫的控制作用。接种LP-BM5病毒后,这些...
LACTOBACILLUS REUTERI ATCC PTA 6475 FOR USE IN PREVENTION OR TREATMENT OF BONE LOSS IN MAMMALSThe present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The ...
LACTOBACILLUS REUTERI ATCC PTA 6475 FOR USE IN PREVENTION OR TREATMENT OF BONE LOSS IN MAMMALSThe present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The ...
reuteri (ATCC PTA 6475) and its heat-killed (postbiotic) form on Ovx-induced bone loss. Adult female mice (BALB/c) were randomly divided into four groups: group C—control (sham); group OVX-C—Ovx; group OVX-POS—Ovx heat-killed probiotic; group OVX-PRO—Ovx probi...
The treatment of Bacillus acidi lactici REUTERI ATCC PTA 6475 or osteoporosis IN mammals for using IN to preventThe method of the present invention includes the lactic bacteria strain selected, effectively prevent in bone loss people and bacterial strain having a selection according to the method ...
The folylpolyglutamate synthase gene in probiotic Lactobacillus reuteri ATCC PTA 6475 contributes to its anti‐inflammatory activity.: P‐026.F ZhangD SaulnierC ThomasJ SpinlerP HemarajataA GrimmT HongM KalkumJ VersalovicInflammatory Bowel Diseases...